APA (7th ed.) Citation

Hardenberg, J. v., Hartmann, S., Nitschke, K., Worst, T., Nuhn, P., Weis, C. T., & Erben, P. (2019). Programmed death ligand 1 (PD-L1) status and tumor-infiltrating lymphocytes in hot spots of primary and liver metastases in prostate cancer with neuroendocrine differentiation. Clinical genitourinary cancer, 17(2), . https://doi.org/10.1016/j.clgc.2018.12.007

Chicago Style (17th ed.) Citation

Hardenberg, Jost von, Sarah Hartmann, Katja Nitschke, Thomas Worst, Philipp Nuhn, Cleo-Aron Thias Weis, and Philipp Erben. "Programmed Death Ligand 1 (PD-L1) Status and Tumor-infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer with Neuroendocrine Differentiation." Clinical Genitourinary Cancer 17, no. 2 (2019). https://doi.org/10.1016/j.clgc.2018.12.007.

MLA (9th ed.) Citation

Hardenberg, Jost von, et al. "Programmed Death Ligand 1 (PD-L1) Status and Tumor-infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer with Neuroendocrine Differentiation." Clinical Genitourinary Cancer, vol. 17, no. 2, 2019, https://doi.org/10.1016/j.clgc.2018.12.007.